Last reviewed · How we verify
HIONFURT Motion Sickness (PREVENT)
At a glance
| Generic name | PREVENT |
|---|---|
| Sponsor | Puning Huiyu E-Commerce Co., Ltd. |
| Drug class | Non-Standardized Plant Allergenic Extract [EPC] |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial (PHASE3)
- Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion (PHASE2)
- What Works - Malawi Moyo Olemekeza (NA)
- Doxi-Rio: Study on the Use of Doxycycline to Prevent Sexually Transmitted Infections in Rio de Janeiro (NA)
- Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adults
- Investigating the Impact of Cold Atmospheric Plasma Treatment on Wound Healing at Cannulation Sites in Patients Following Extracorporeal Life Support (NA)
- Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial (PHASE2)
- Dendritic Cell Vaccine to Prevent COVID-19 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |